Lobbying Relationship


The Biosimilars Forum

More records

Lobbying firm


More records

  • Medicare reimbursement issues, FDA regulation of biosimilars.

Duration: to

General Issues: Medicare/Medicaid, Pharmacy, Health Issues, Medical/Disease Research/Clinical Labs

Spending: about $1,680,000 (But it's complicated. Here's why.)

Agencies lobbied since 2015: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS)

Related Foreign Entities: Boehringer Ingelheim GmbH (55216 Ingelheim am Rhein, GER); contribution to lobbying: $0; ownership 100%; Merck KGaA (64293 Darmstadt, GER); contribution to lobbying: $0; ownership 100%; Samsung Bioepis (Incheon, KOR); contribution to lobbying: $0; ownership 100%; Novartis AG (Basel, SUI); contribution to lobbying: $0; ownership 100%; Teva Pharmaceutical Industries Ltd. (Petach Tikva, ISR); contribution to lobbying: $0; ownership 100%

Bills mentioned

S.934: FDA Reauthorization Act of 2017

Sponsor: Lamar Alexander (R-Tenn.)

H.R.2430: FDA Reauthorization Act of 2017

Sponsor: Greg Walden (R-Ore.)

H.R.1625: Consolidated Appropriations Act, 2018

Sponsor: Edward Royce (R-Calif.)

Show All Mentioned Bills


Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Christopher DeLacy Counsel, House Science Cmte., Technology Subcmte. Counsel, Senator John Warner
Paul Bock Chief of Staff, Senator Herb Kohl Counsel, House Judiciary Committee
Kathyrn Lehman Chief Counsel, Sbcmte. on Constitution, H. Judiciary Cmte.
Kathryn Lehman Special Assistant to Speaker of the House Policy Director, House Majority Whip Director of Coalition Outreach, Speaker of House Chief of Staff, House Republican Conference
Karl Koch Chief of Staff, Rep. Jim Davis
Matthew Banfield Staff Assistant, Senator Tim Kaine
Kerry Feehery Staff Asst., Special Asst., Dep. Press Sec., Sen. Connie Mac Press Secretary, Joint Economic Committee Policy Analyst, Senate Budget Committee Communications Director, Sen. Mel Martinez Director, State Office of Sen. George LeMieux Chief of Staff, Sen. George LeMieux
Michael Werner n/a
Richard Gold n/a
Miranda Franco n/a
Scott Mason n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page